Medicare Enrolled
Dr. Wieslawa Pekal, M.D.
Hematology · Asheville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pekal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pekal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pekal
Dr. Wieslawa Pekal is a hematology specialist in Asheville, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pekal performed 76,203 Medicare services across 4,194 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pekal received a total of $7,921 from 60 pharmaceutical and/or device companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pekal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NC
$7,921 industry payments
Medicare Practice Summary
Medicare Utilization ↗76,203
Medicare services
Top 5% in NC for hematology
4,194
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,810 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,770 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 9,100 | $43 | $157 |
| Anti-nausea injection (aprepitant) | 8,190 | $1 | $6 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
6,300 | $38 | $136 |
| Denosumab injection (Prolia/Xgeva) | 5,640 | $18 | $64 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
4,900 | $0 | $18 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,150 | $6 | $25 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
3,050 | $36 | $141 |
| Iron infusion (Monoferric) | 2,700 | $16 | $71 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,501 | $0 | $1 |
| Paclitaxel chemotherapy injection | 2,397 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,925 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,764 | $8 | $9 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,694 | $0 | $1 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
1,292 | $3 | $135 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,050 | $1 | $41 |
| Injection, atropine sulfate, 0.01 mg | 800 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
506 | $91 | $390 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
462 | $61 | $277 |
| Injection, leucovorin calcium, per 50 mg | 457 | $3 | $14 |
| Anti-nausea injection (ondansetron/Zofran) | 440 | $0 | $3 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
346 | $95 | $421 |
| Injection, irinotecan, 20 mg | 339 | $2 | $35 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
293 | $2 | $7 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
276 | $10 | $67 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 241 | $3 | $42 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
218 | $21 | $103 |
| Injection, potassium chloride, per 2 meq | 200 | $0 | $4 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
162 | $11 | $66 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
156 | $2 | $39 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
121 | $2 | $12 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
118 | $45 | $208 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
101 | $15 | $65 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
101 | $52 | $234 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
101 | $132 | $550 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
94 | $1 | $4 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
94 | $7 | $126 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
82 | $47 | $205 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
80 | $70 | $210 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
74 | $21 | $164 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
67 | $62 | $313 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $118 | $509 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
61 | $4 | $12 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 52 | $135 | $603 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 51 | $196 | $1,533 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
48 | $2 | $9 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
47 | $9 | $40 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
46 | $24 | $135 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
45 | $8 | $26 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
42 | $1,082 | $4,447 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
41 | $1 | $2 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
38 | $25 | $121 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
38 | $16 | $83 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
37 | $1 | $21 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
34 | $41 | $177 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
30 | $14 | $63 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
24 | $23 | $105 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
23 | $3 | $11 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
22 | $47 | $368 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
22 | $172 | $613 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
22 | $1 | $6 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
18 | $163 | $733 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
18 | $12 | $71 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
14 | $95 | $404 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
12 | $1,082 | $4,447 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.9% high complexity
66.1% medium
7.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,921
Total received (2018-2024)
Avg $1,132/year across 7 years
Top 27% in NC for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
224
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,111 (77.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,810 (22.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,522
2023
$1,239
2022
$2,302
2021
$890
2020
$264
2019
$621
2018
$1,082
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$350
Merck Sharp & Dohme LLC
$118
Novartis Pharmaceuticals Corporation
$78
Karyopharm Therapeutics Inc.
$78
Incyte Corporation
$58
GENZYME CORPORATION
$55
Celgene Corporation
$50
Alexion Pharmaceuticals, Inc.
$49
Deciphera Pharmaceuticals Inc.
$48
Bayer Healthcare Pharmaceuticals Inc.
$48
Eisai Inc.
$47
Daiichi Sankyo Inc.
$46
AstraZeneca Pharmaceuticals LP
$43
SOBI, INC
$41
E.R. Squibb & Sons, L.L.C.
$31
Organon Llc
$31
Rigel Pharmaceuticals, Inc.
$26
Janssen Pharmaceuticals, Inc
$26
ABBVIE INC.
$24
GlaxoSmithKline, LLC.
$24
Exelixis Inc.
$22
SERVIER PHARMACEUTICALS LLC
$22
GE HEALTHCARE
$22
Takeda Pharmaceuticals U.S.A., Inc.
$21
Genmab U.S., Inc.
$21
PFIZER INC.
$21
JAZZ PHARMACEUTICALS INC.
$19
Acrotech Biopharma Inc.
$19
ADC Therapeutics America, Inc.
$18
Pharmacosmos Therapeutics Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$17
Adaptive Biotechnologies Corporation
$15
Apellis Pharmaceuticals, Inc.
$15
Top 3 companies account for 35.8% of 2024 payments
All-time payments by company (2018-2024) ›
Rigel Pharmaceuticals, Inc.
$1,196
Janssen Biotech, Inc.
$896
E.R. Squibb & Sons, L.L.C.
$667
Novartis Pharmaceuticals Corporation
$508
PFIZER INC.
$448
Genentech USA, Inc.
$294
Athenex Pharmaceutical Division, LLC
$291
Amgen Inc.
$280
AstraZeneca Pharmaceuticals LP
$222
Lilly USA, LLC
$217
GlaxoSmithKline, LLC.
$189
Merck Sharp & Dohme LLC
$176
Stemline Therapeutics Inc.
$175
Daiichi Sankyo Inc.
$162
Incyte Corporation
$153
BeiGene USA, Inc.
$152
GENZYME CORPORATION
$139
Deciphera Pharmaceuticals Inc.
$119
Boehringer Ingelheim Pharmaceuticals, Inc.
$114
Janssen Scientific Affairs, LLC
$100
Takeda Pharmaceuticals U.S.A., Inc.
$95
Bayer Healthcare Pharmaceuticals Inc.
$91
Celgene Corporation
$87
Karyopharm Therapeutics Inc.
$78
Alexion Pharmaceuticals, Inc.
$75
Eisai Inc.
$72
EISAI INC.
$65
SOBI, INC
$56
Astellas Pharma US Inc
$50
Seagen Inc.
$45
ABBVIE INC.
$44
SERVIER PHARMACEUTICALS LLC
$44
Genmab U.S., Inc.
$42
ARRAY BIOPHARMA INC
$37
MorphoSys, US Inc.
$35
ADC Therapeutics America, Inc.
$34
Pharmacosmos Therapeutics Inc.
$32
Organon Llc
$31
Janssen Pharmaceuticals, Inc
$26
G1 Therapeutics, Inc.
$23
TAIHO ONCOLOGY, INC.
$23
Exelixis Inc.
$22
GE HEALTHCARE
$22
AbbVie Inc.
$22
Kite Pharma, Inc.
$21
Agios Pharmaceuticals, Inc.
$20
JAZZ PHARMACEUTICALS INC.
$19
Acrotech Biopharma Inc.
$19
Acrotech Biopharma LLC
$19
Regeneron Healthcare Solutions, Inc.
$18
NOVARTIS PHARMACEUTICALS CORPORATION
$18
Novocure Inc.
$17
Gilead Sciences, Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$17
Octapharma USA, Inc.
$16
Adaptive Biotechnologies Corporation
$15
Kyowa Kirin, Inc.
$15
Apellis Pharmaceuticals, Inc.
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Spectrum Pharmaceuticals Inc.
$13
Top 3 companies account for 34.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CREON · DARZALEX · Doptelet · ELIQUIS · ENHERTU · ENJAYMO · ERLEADA · Empaveli · Enhertu · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Monoferric · NINLARO · Nplate · Nubeqa · OJJAARA · ONTRUZANT · OPDIVO · Optune · Oraxol · Orserdu · PADCEV · PANZYGA · PIQRAY · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Rezlidhia · SARCLISA · SYNAGIS · Stivarga · TAGRISSO · TALVEY · TECENTRIQ · TECVAYLI · TIBSOVO · Tavalisse · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Vectibix · Venclexta · XALKORI · XGEVA · XPOVIO · XTANDI · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematologists within 10 mi
10
Per 100K population
3.7
County median income
$70,578
Nearest hospital
MEMORIAL MISSION HOSPITAL AND ASHEVILLE SURGERY CE
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pekal is a mixed practice specialist, with above-average Medicare volume (top 5% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pekal experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Pekal performed 13,770 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pekal receive payments from pharmaceutical companies?
Yes. Dr. Pekal received a total of $7,921 from 60 companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pekal's costs compare to other hematologists in Asheville?
Dr. Pekal's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pekal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Asheville
Browse hematologists in Asheville ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in NC
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in NC
Which NC hematologists receive the most from drug and device companies.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology